C-AMP & CONTRACTILE REGULATION IN AIRWAY SMOOTH MUSCLE
营
基本信息
- 批准号:3344234
- 负责人:
- 金额:$ 15.24万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1984
- 资助国家:美国
- 起止时间:1984-08-01 至 1990-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
In asthma therapy a major goal is to achieve reversal of airway smooth
muscle spasm. The most commonly used bronchodilators, beta adrenergic
agonists and the methylxanthines, are thought to act via the cyclic AMP
pathway. The ability of isoproterenol to relax contracted airway smooth
muscle differs depending on the particular agonist used to contract the
tissue. A working hypothesis is that certain agents (methacholine) produce
contractions resistant to isoproterenol because they directly inhibit the
cyclic AMP pathway. Other contractile agents (serotonin, histamine) are
more easily reversed by isoproterenol and we will test the hypothesis that
these do not inhibit the cyclic AMP pathway. We will contract isolated
airway smooth muscle strips with methacholine, seratonin, histamine and
potassium and compare the relative ability of these four agents to inhibit
isoproterenol-induced relaxation, cyclic AMP increases and protein kinase
activation. We will use canine trachealis because many comparable
preparations can be collected from one donor and because the cellular
homogeneity of samples permits valid correlation of mechanical events with
changes in biochemical composition. The beta receptor density in cervical
trachealis is greater than that in thoracic trachialis. We will perform
experiments on both regions in order to evaluate the influence that natural
variation in beta receptor density has on the functional antagonism between
contractile and relaxant agonists. A major theory of asthma proposes that
the molecular basis of asthma is a deficiency in the beta receptor cyclase
system, and the reduced beta receptor density in thoracic trachealis
provides an in vitro model of such a phenomenon. Experiments will be done
to test the ability of methacholine, serotonin, histamine and potassium to
resist relaxation, cyclic AMP increases and protein kinase activation
induced by prostaglandin E2, Forskolin, cyclic AMP analogues,
methylxanthines and non-cyclic AMP-mediated relaxants such as
nitroprusside. These relaxants activate the cyclic AMP pathway at sites
progressively farther along in the causal sequence. These results should
facilitate localization of the site of action of methacholine since a
relaxant which activates at a subsequent site should by-pass the
methacholine inhibited site and readily relax the contraction. After the
basic behavior of the system and mechanical-biochemical correlations have
been worked out in the canine trachealis, experiments will be done to
extend these principles to more peripheral airways.
在哮喘治疗的一个主要目标是实现气道平滑的逆转
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GILBERT A RINARD其他文献
GILBERT A RINARD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GILBERT A RINARD', 18)}}的其他基金
MECHANISMS OF VERAPAMIL INHIBITION OF BRONCHOSPASM
维拉帕米抑制支气管痉挛的机制
- 批准号:
3343525 - 财政年份:1984
- 资助金额:
$ 15.24万 - 项目类别:
MECHANISMS OF VERAPAMIL INHIBITION OF BRONCHOSPASM
维拉帕米抑制支气管痉挛的机制
- 批准号:
3343526 - 财政年份:1984
- 资助金额:
$ 15.24万 - 项目类别: